Citation Impact
Citing Papers
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Point-of-Care Testing
2012 Standout
Recreation of the terminal events in physiological integrin activation
2010
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Modulation of Integrin Activation by an Entropic Spring in the β-Knee
2010 StandoutNobel
Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
2003
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Contribution of platelets to tumour metastasis
2011 Standout
Acute microvascular platelet aggregation after subarachnoid hemorrhage
2005
Platelet integrins and immunoreceptors
2007
The Effects of Fibrinogen Levels on Thromboelastometric Variables in the Presence of Thrombocytopenia
2009
Perioperative Management of Antithrombotic Therapy
2012 Standout
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab
2015
The Toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade
2013 StandoutNobel
Lateral Clustering of Platelet GP Ib-IX Complexes Leads to Up-regulation of the Adhesive Function of Integrin αIIbβ3
2002
Effects of inhibition of P2Y1 and P2Y12 on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry
2003 StandoutNobel
Pharmacological control of platelet function
2001
Immune Thrombocytopenic Purpura
2002 Standout
Single-molecule force spectroscopy: optical tweezers, magnetic tweezers and atomic force microscopy
2008 Standout
Platelets in inflammation and atherogenesis
2005 Standout
Autologous platelets as a source of proteins for healing and tissue regeneration
2003 Standout
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Surface plasmon resonance and free oscillation rheometry in combination: a useful approach for studies on haemostasis and interactions between whole blood and artificial surfaces
2002 StandoutNobel
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
2013 Standout
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Small peptide GP IIb/IIIa receptor inhibitors as upstream therapy in non–ST-segment elevation acute coronary syndromes: results of the PURSUIT, PRISM, PRISM-PLUS, TACTICS, and PARAGON trials
2001
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Therapeutic expression of the platelet-specific integrin, IIb 3, in a murine model for Glanzmann thrombasthenia
2005
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Labeling of the Internal Pool of GP IIb-IIIa in Platelets by c7E3 Fab Fragments (abciximab): Flow and Endocytic Mechanisms Contribute to the Transport
1999
Integrin Signaling: The Platelet Paradigm
1998
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention
2001
Binding strength and activation state of single fibrinogen-integrin pairs on living cells
2002
Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa
2015
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend
2008
Smart wound dressings for wound healing
2021 Standout
Integrin αIIbβ3 outside-in signaling
2017
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Recombinant human natural autoantibodies against GPIIb/IIIa inhibit binding of autoantibodies from patients with AITP
1998
Pathophysiology and Treatment of Coagulopathy in Massive Hemorrhage and Hemodilution
2010
A revolution in optical manipulation
2003 StandoutNature
Wound Healing: A Cellular Perspective
2018 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and α v β 3 Integrins
1998
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of RE Jordan being referenced
Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets
1996